Oberheiden Law Group

Dupixent lawsuits allege that the drug’s manufacturers failed to warn asthma patients and others about the prescription drug’s link to the rare but aggressive form of skin cancer, cutaneous T-cell lymphoma (CTCL). Patients who developed CTCL after using this injectable medication are encouraged to speak with an attorney about their legal rights. If you have questions about filing a Dupixent lawsuit, talking to a lawyer is the first major step toward making an informed decision.